Irreversible electroporation in liver and pancreatic cancer

Home  /  National Uptake and Case Studies  /  Irreversible electroporation in liver and pancreatic cancer
CountryAgencyYear work was carried outLinkDetails of use
AustriaLBI-HTA2019-National adaptation. Made no changes. Added executive summary in German.
AustriaGOEG2019-Dissemination to MoH.
ItalyASSR RER2019-National adaptation. Added local information and budget impact / cost-effectiveness analysis.
ItalyAGENAS2019Ongoing.Translation of the report summary.
SlovakiaUNIBA2019-National adaptation. Added local information and budget impact / cost-effectiveness analysis.
SpainAVALIA2019-National adaptation. Added local information.
SpainSCS2019-Assessment disseminated to clinicians.
United Kingdom (England)NICE2019-Read the assessment for background information. EUnetHTA assessments are included in NHS Evidence.
United Kingdom (Scotland)SHTG2019-Dissemination. Alerted clinicians in country working in this area. Included in regular 'horizon scanning' update sent to external stakeholders.